Truth Social American Red State REITs ETF (TSRS)
Live price chart, market sentiment, and community perspectives for Truth Social American Red State REITs ETF (AMEX: TSRS).
Live price chart, market sentiment, and community perspectives for Truth Social American Red State REITs ETF (AMEX: TSRS).
On our desk, the structural conversation surrounding TSRS revolves entirely around its political branding versus execution costs. While the mandate targets companies operating in Red States—defined as states where a Republican won at least two out of the last three presidential elections—the commercial reality is stark. At 0.65%, the expense ratio is nearly ten times higher than generic REIT benchmarks like Schwab that charge a mere 7 basis points. For a fund holding just 27 positions and managing under $3 million in total assets, the thematic angle feels more like a retail marketing ploy than an institutional-grade vehicle. Investors are paying a massive premium for a political label without gaining any structural diversification benefits.
From a quantitative and valuation perspective, analyzing TSRS requires looking past the ideological packaging to examine the underlying real estate fundamentals. The portfolio tracks the MarketVector iREIT Red St REITs TR USD index, translating to a P/E ratio around 27.19 and a modest monthly payout structure with a 59% payout ratio. Since its inception on December 30, 2025, it has posted an annualized return of roughly 9.57%, trailing broader indexes like SPY. When preparing an asset allocation thesis for clients interested in political screening strategies, one must weigh these performance figures against the drag of the 65 basis point fee and the potential for increased volatility during macro sector pullbacks.
Reviewing the liquidity metrics for TSRS raises immediate red flags regarding execution risk. With an average daily volume lingering around 1,500 shares—and frequently dropping below 500—positioning in and out of this ETF can incur substantial slippage. The 30-day median bid/ask spread and wider market quotes point to severe friction for anyone trying to trade meaningful block sizes. Furthermore, total assets hovering around $2.75 million and only 100,000 shares outstanding place this product squarely in micro-ETF territory, carrying inherent closure or liquidity impairment risks that far outweigh its 3.93% SEC yield.
Explore plasma cleansing, somatic organ swaps, and BCI.